Travere Therapeutics (TVTX) Cash from Investing Activities Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Travere Therapeutics | 4.34 Bn | 4.26 Bn | 102.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.12% |
| Dec 31, 2025 | 3.54% |
| Sep 30, 2025 | 31.99% |
| Jun 30, 2025 | -40.99% |
| Mar 31, 2025 | 0.86% |
| Dec 31, 2024 | -121.09% |
| Sep 30, 2024 | 59.52% |
| Jun 30, 2024 | 2.55% |
| Mar 31, 2024 | 62.10% |
| Dec 31, 2023 | -35.67% |
| Sep 30, 2023 | 23.09% |
| Jun 30, 2023 | -23.25% |
| Mar 31, 2023 | -12.18% |
| Dec 31, 2022 | -223.87% |
| Sep 30, 2022 | 45.88% |
| Jun 30, 2022 | -23.67% |
| Mar 31, 2022 | 51.72% |
| Dec 31, 2021 | -24.71% |
| Sep 30, 2021 | 49.12% |
| Jun 30, 2021 | -75.67% |
| Mar 31, 2021 | -61.05% |
| Dec 31, 2020 | -4.55% |
| Sep 30, 2020 | -23.10% |
| Jun 30, 2020 | 114.74% |
| Mar 31, 2020 | 26.84% |
| Dec 31, 2019 | -4.32% |
| Sep 30, 2019 | 33.02% |
| Jun 30, 2019 | 43.88% |
| Mar 31, 2019 | 18.18% |
| Dec 31, 2018 | -109.75% |
| Mar 31, 2018 | -74.01% |